Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
Clinical trial NCT01031901 · COMPLETED
Trial details
- NCT number
- NCT01031901
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.